NCT02043717View on ClinicalTrials.gov

Increased Vitamin D Reduces Pulmonary Exacerbations in CF

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

June 30, 2015

Conditions
Cystic Fibrosis
Interventions
DIETARY_SUPPLEMENT

Vitamin D

"Supplementing oral cholecalciferol according to the new guidelines by:~Tangpricha V, Kelly a, Stephenson a, Maguiness K, Enders J, Robinson K a, et al. An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation. The Journal of clinical endocrinology and metabolism \[Internet\]. 2012 May \[cited 2012 Oct 31\];97(4):1082-93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22399505"

Trial Locations (1)

Unknown

Hadassah Medical Organization, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT02043717 - Increased Vitamin D Reduces Pulmonary Exacerbations in CF | Biotech Hunter | Biotech Hunter